Navigation Links
Danish Hotspot in Personalized Medicine

COPENHAGEN, November 12 /PRNewswire/ -- The Danish biotech cluster known as Medicon Valley has, within a short period, grown into a global hotspot in the field of personalized medicine, and finds itself increasingly in favor among big pharma and big biotech. Experience Danish competencies at the 3rd Annual Personalized Medicine Meeting in San Francisco from 12th - 13th November.

With over 10 research institutions and 15-20 private companies engaged in personalized medicine, the Danish biotech cluster known as Medicon Valley has in record time become a strong player in currently one of the hottest research fields within the pharmaceutical industry.

Several of these Danish players operate on an individual basis, although many are also involved in collaborative research efforts, including the Danish Center for Translational Breast Cancer Research, the siRNA Delivery Center, the Danish microRNA consortium and special research departments at the University of Copenhagen and the Technical University of Denmark.

This is one reason why Denmark is participating in 3rd Annual Personalized Medicine Meeting in San Francisco, where Director of Knowledge and Communications at Danish Medicines Agency Kaare Geil is in the panel discussion on the second day to give a European/Danish perspective on the topic: Who Will Pay? The Economics of Personalized Medicine. Kaare Geil says: "Denmark has a national cancer plan, which is very clear on personalized medicine. The ministry of health as well as the ministry of science, has specific programs to support and enable the implementation of personalized medicines in our systems."

S0ren M. Echwald, M.Sc., Ph.D., who is Vice President and responsible for Business Development at Exiqon will be hosting a table discussion at the conference. "Exiqon is very committed to our diagnostic vision, and is active with several diagnostic projects," says S0ren M. Echwald. "With Exqion's key technologies, the growing role of microRNA in classification of cancers, and the strong clinical network in Scandinavia, we feel ideally positioned to contribute to the improvement of cancer treatment selection."

Business Development Manager Vibeke Dalhoff from Copenhagen Capacity, the official investment promotion agency of the Capital Region of Denmark explains: "Denmark is absolutely world-class within biomedicine and we are pioneers within personalized medicine, with strong competencies in the therapeutic and cancer fields, among others."

Gitte Pedersen, special advisor with the sister organization Invest in Denmark: "Denmark is in a unique position. We excel at developing medicine, we have core competencies within system biology, which is the toolbox for personalized medicine, and we have a health service that can see the advantages of implementing individualized medicine and engage in an open dialog between companies and the authorities".

Given this cocktail of companies, research environment and interest from the public sector, international pharmaceutical companies working on personalized medicine have a strong focus on Denmark and Medicon Valley.

"There is growing interest in the Danish competencies within individualized medicine", says Vibeke Dalhoff.

These companies work with personalized medicine in Denmark:

Within diagnostics: Dako, Exiqon, FluimediX and Medical Prognostic Institute.

Within drug discovery: Genmab, Novo Nordisk, Pharmexa, Santaris Pharma and TopoTarget.

For further information:

Vibeke Dalhoff




Gitte Pedersen

tel: +1-212-665-8626


SOURCE Copenhagen Capacity
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. The 3rd Annual Burrill Personalized Medicine Meeting November 12-13, 2007 in San Francisco
2. HHS Issues First Department-Wide Report on Personalized Health Care
3. Agendia Joins the Personalized Medicine Coalition (PMC)
4. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
5. Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers
6. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
7. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
8. Nobel Award in Medicine Holds Strong Messsage for Animal Activists
9. Companys Partner Completes Trial Production of a New Antiviral Medicine
10. Luminex Corporation Reaches Settlement With Rules Based Medicine, Inc.
11. Pioneer in Reproductive Medicine Opens The Countrys First Comprehensive Fertility Practice
Post Your Comments:
(Date:10/9/2015)... ROCKVILLE, Md. , Oct. 9, 2015 ... company developing next generation vaccines based on the ... into an exclusive worldwide licensing agreement with Astellas ... or prevention of any and all allergic diseases ... Therapeutics will receive an upfront payment of $300 ...
(Date:10/8/2015)... UK (PRWEB) , ... October 08, 2015 , ... Researchers ... literally see inside the living brain, providing a new tool to study how diseases ... is reported by Woo June Choi and Ruikang Wang of the UW Department of ...
(Date:10/8/2015)... Pa. , Oct. 8, 2015  Clarkston Consulting, ... the call for applications for the 2016 Clarkston Scholars ... a life sciences related field of study, a $10,000 ... selected Clarkston Scholar will receive exposure to the life ... in Pennsylvania Bio events over the course of the ...
(Date:10/8/2015)... , Oct. 8, 2015  Today, DuPont and ... for genome editing, jointly announced a strategic alliance. ... cross-licensed their respective patent portfolios, with DuPont receiving ... in major row crops, and non-exclusive rights in ... --> --> In ...
Breaking Biology Technology:
... Gretel ventured into the forest, they left a trail ... world, cellular phones, Global Positioning System (GPS), WiFi, and ... friends, family, and colleagues while helping us find our ... ubiquity of such devices, with few exceptions, today,s firefighters ...
... Kendle (Nasdaq: KNDL ), a leading, ... of its senior clinical development experts will present ... Association (DIA) 47th Annual Meeting, June 19-23, 2011, ... including the benefits of hybrid monitoring; finding an ...
... New Generation of the Ziehm Vision RFD Offers,Lower-Cost ... has launched a new generation of the Ziehm Vision,RFD mobile ... it to be used over an almost unlimited period,of time, ... to its mobility and significantly lower investment costs,the Ziehm Vision ...
Cached Biology Technology:
(Date:9/30/2015)... Sept. 30, 2015  With nearly 300,000 Americans living ... new SCIs estimated to reach 12,500 annually, the role ... Resource Services for Independent Living (SCRS-IL) is increasingly ... California opening doors to independence for ... and services, notably assistive technology services and education. ...
(Date:9/29/2015)... SUNNYVALE, Calif. , Sept. 29, 2015 ... technology improves employee productivity while also saving energy ... features such as Low Power Active Mode and embedded ... workplace transformation Fujitsu today shows that ... of new and refreshed models to its enterprise desktop ...
(Date:9/28/2015)... Sept. 28, 2015  The monitoring of vital ... body temperature, is an essential component of patient ... of deterioration in a patient,s condition. However, in ... are typically taken during routine observation rounds only ... patient deteriorates between these observation rounds, the warning ...
Breaking Biology News(10 mins):
... VTT Technical Research Centre of Finland indicates that there is ... sold in Finland as regards fuel consumption in normal driving. ... using six used cars of different make under laboratory conditions. ... fuel consumption is significantly higher with 95E10 petrol than with ...
... A group of scientists at the Instituto Gulbenkian de Cincia, ... skeleton and organ size. The team, led by Florence Janody, ... the proteins that regulates the skeleton of the cell also ... and proliferation. Their findings have implications for cancer research, as ...
... organ in the human body that metabolizes foreign compounds such ... liver as an alarm system, researchers are starting to better ... their effects on the human body. One ... the Virginia Tech Institute of Critical Technology and Applied Science,s ...
Cached Biology News:
Rabbit polyclonal to Olfactory Receptor LS189744 ( Abpromise for all tested applications)....
Recognizes the VZV nucleocapsid by indirect immunofluorescence and immunoprecipitation. Shows cross-reactivity to HSV....
Mouse monoclonal [11C9] to Zeralenone ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule conjugated to BSA: Zeralenone...
AK6 Antibody...
Biology Products: